WO2024261713 - TOPICAL REGIMEN FOR TREATING COLD SORES
National phase entry:
Publication Number
WO/2024/261713
Publication Date
26.12.2024
International Application No.
PCT/IB2024/056075
International Filing Date
21.06.2024
Title **
[English]
TOPICAL REGIMEN FOR TREATING COLD SORES
[French]
RÉGIME TOPIQUE POUR TRAITER DES ESCARRES FROIDES
Applicants **
HALEON UK IP LIMITED
Building 5, First Floor, The Heights
Wybridge Surrey KT13 0NY, GB
Inventors
NEL, Jonathan
Route de I'Etraz 2
1260 Nyon, CH
POLYANKER, Iuliia
Route de I'Etraz 2
1260 Nyon, CH
GUNDUGOLA, Sudha
184 Liberty Corner Rd.
Warren, New Jersey 07059, US
Priority Data
63/509,839
23.06.2023
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| * | |
International Searching Authority |
EPO
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Translation |
|
Recalculate
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing | 1009 | |
| EPO | Filing, Examination | 4588 | |
| Japan | Filing | 590 | |
| South Korea | Filing | 574 | |
| USA | Filing, Examination | 2710 |
Total: 9471 USD
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Abstract[English]
Therapeutic regimens for treating cold sores (fever blisters) associated with herpes infection, and kits therefor.[French]
L'invention concerne des régimes thérapeutiques pour traiter des escarres froides (bouton de fièvre) associées à une infection par des herpès, ainsi que des kits s'y rapportant.